VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,018 | -67.1% | 131,557 | -48.9% | 0.00% | -75.0% |
| Q2 2023 | $6,126 | +107.4% | 257,536 | +121.7% | 0.00% | +300.0% |
| Q1 2023 | $2,954 | +1.8% | 116,143 | +16.9% | 0.00% | 0.0% |
| Q4 2022 | $2,901 | -100.0% | 99,320 | -84.8% | 0.00% | -93.3% |
| Q3 2022 | $13,409,000 | +6225.0% | 653,751 | +3473.4% | 0.02% | – |
| Q2 2022 | $212,000 | -32.5% | 18,295 | +7.6% | 0.00% | – |
| Q1 2022 | $314,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 944,092 | $15,530,000 | 5.65% |
| Ally Bridge Group (NY) LLC | 904,978 | $14,887,000 | 4.38% |
| COMMODORE CAPITAL LP | 667,674 | $10,983,000 | 2.90% |
| FRAZIER MANAGEMENT LLC | 1,505,200 | $24,761,000 | 1.98% |
| Logos Global Management LP | 1,500,000 | $24,675,000 | 1.78% |
| Ghost Tree Capital, LLC | 350,000 | $5,758,000 | 1.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 106,078 | $1,745,000 | 0.99% |
| Vivo Capital, LLC | 1,300,000 | $21,385,000 | 0.96% |
| ACUTA CAPITAL PARTNERS, LLC | 135,807 | $2,234,000 | 0.79% |
| BVF INC/IL | 804,126 | $13,228,000 | 0.52% |